| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 02/02/2000 | EP0767794B1 Phosphinic acid derivatives |
| 02/02/2000 | EP0751783B1 Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic use of aminoacetylmercapto derivatives |
| 02/02/2000 | EP0558727B1 Bone-growth-stimulating composition |
| 02/02/2000 | EP0397834B1 Method for identifying active domains and amino acid residues in polypeptides and hormone variants |
| 02/02/2000 | CN1243460A Film coatings and film coating compositions based on dextrin |
| 02/02/2000 | CN1243438A Pharmaceutical composition of fenofibrate with high biological utilizing rate |
| 02/02/2000 | CN1242985A Compounded calcium preparation, preparing method and use thereof |
| 02/01/2000 | US6020383 Administering tert-butylhydroquinone |
| 02/01/2000 | US6020378 Method for selectively altering body fat level, feed efficiently, or weight gain |
| 02/01/2000 | US6020356 Pharmaceutical composition for the treatment of autoimmune diseases |
| 02/01/2000 | US6020351 Carotenoid-nicotinamide-zinc compositions and methods of treatment using same |
| 02/01/2000 | US6020349 Constrained somatostatin agonists and antagonists |
| 02/01/2000 | US6020335 (N-(pyridinylmethyl)-heterocyclic)ylideneamine compounds as nicotinic acetylcholine receptor binding agents |
| 02/01/2000 | US6020330 Hypolipidemic 1,4-benzothiazepine-1,1-dioxides |
| 02/01/2000 | US6020326 Method for inhibition of bone growth by anionic polymers |
| 02/01/2000 | US6020200 Encapsulation compositions and methods |
| 02/01/2000 | US6020199 Antisense modulation of PTEN expression |
| 02/01/2000 | US6020157 Polynucleotides encoding HFGAN72X receptor |
| 01/27/2000 | WO2000004171A1 Treatment of diabetes with synthetic beta cells |
| 01/27/2000 | WO2000004144A1 Snurpotine i human m3g-cap specific nucleus import receptor protein with new domain structure, the production and use thereof |
| 01/27/2000 | WO2000004137A1 Human aspartic proteases |
| 01/27/2000 | WO2000004011A1 Cyclic compounds useful in the treatment of dyslipidaemia, atherosclerosis and diabetes, pharmaceutical compositions and preparation process |
| 01/27/2000 | WO2000004010A1 Bicyclohexane derivatives |
| 01/27/2000 | WO2000004006A1 Polycyclic thiazolidin-2-ylidene amines, method for the production and use thereof as medicaments |
| 01/27/2000 | WO2000004002A1 Polyhydroalkylpyrazine derivatives and their preparation and medicines containing them |
| 01/27/2000 | WO2000003992A1 Quinoline derivatives |
| 01/27/2000 | WO2000003991A1 Quinoline derivatives |
| 01/27/2000 | WO2000003742A2 Solid oral dosage form comprising a combination of metformin and glibenclamide |
| 01/27/2000 | WO2000003704A1 Macrophage scavenger receptor antagonists |
| 01/27/2000 | WO1998046257A8 Compositions comprising conjugates of stable, active, human ob protein with antibody fc chain and methods |
| 01/27/2000 | DE19918588A1 Piperidinverbindung Piperidine |
| 01/27/2000 | DE19833105A1 New N-amidinophenyl-1-carboxymethyl-4-piperidinepropanamide derivatives useful as antithrombotic, antiaggregatory, antitumor, antimetastatic, antiinflammatory and anti-osteoporosis agents |
| 01/27/2000 | DE19831878A1 New polycyclic thiazolidin-2-ylidene amines, are lipid metabolism regulators useful for treating obesity or type II diabetes |
| 01/27/2000 | DE19828114A1 Produgs instabiler Inhibitoren der Dipeptidyl Peptidase IV Prodrugs unstable inhibitors of dipeptidyl peptidase IV |
| 01/27/2000 | CA2338122A1 Macrophage scavenger receptor antagonists |
| 01/27/2000 | CA2338054A1 Bicyclohexane derivatives |
| 01/27/2000 | CA2337838A1 Polycyclic thiazolidin-2-ylidene amines, method for the production and use thereof as medicaments |
| 01/27/2000 | CA2337481A1 Cyclic compounds useful in the treatment of dyslipidaemia, atherosclerosis and diabetes, pharmaceutical compositions and preparation process |
| 01/27/2000 | CA2333895A1 Snurportin i human m3g-cap specific nucleus import receptor protein with new domain structure, the production and use thereof |
| 01/27/2000 | CA2303062A1 Human aspartic proteases |
| 01/26/2000 | EP0974668A1 Use of adenoviral E4 reading frames to improve expression of a gene of interest |
| 01/26/2000 | EP0974653A2 Human gastric cancer antigen gene and protein |
| 01/26/2000 | EP0974573A1 Phenylpropenone compounds and medicines containing the same |
| 01/26/2000 | EP0974356A1 Tablets comprising a combination of metformin and glibenclamide |
| 01/26/2000 | EP0974348A1 Visceral fat lowering agent |
| 01/26/2000 | EP0973934A1 Transgenically produced non-secreted proteins |
| 01/26/2000 | EP0973797A1 Peptide compositions which induce immune tolerance and methods of use |
| 01/26/2000 | EP0973792A1 16-hydroxy-11-(substituted phenyl)-estra-4,9-diene derivatives |
| 01/26/2000 | EP0973778A1 4,5,6,7-TETRAHYDRO-THIENO 3,2-c]PYRIDINE DERIVATIVES, THEIR PREPARATION AND USE |
| 01/26/2000 | EP0973744A1 2-amino substituted pyridines for use in the treatment of arteriosclerosis and hyperlipoproteinaemia |
| 01/26/2000 | EP0973738A1 Novel heterocyclic compounds |
| 01/26/2000 | EP0973730A1 Calcilytic compounds |
| 01/26/2000 | EP0973705A1 Chromatographic enantiomer separation of lactones |
| 01/26/2000 | EP0973550A1 Antagonistic anti-avb3 integrin antibodies |
| 01/26/2000 | EP0973534A1 Pharmaceutical compositions having appetite suppressant activity |
| 01/26/2000 | EP0973515A1 Solid compositions suitable for oral administration comprising an alkanoyl-l-carnitine magnesium citrate |
| 01/26/2000 | EP0973512A1 N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 01/26/2000 | EP0973511A1 Use of sibutramine analogues to lower lipid levels |
| 01/26/2000 | EP0835251B1 Process for the production of lipoic acid |
| 01/26/2000 | CN1242704A Tabletted prepn. |
| 01/26/2000 | CN1242367A Spiro [Piperidine-4,1'-pyrrolo[3,4-c] pyrrole] |
| 01/26/2000 | CN1242366A Diaza-spiro [3,5] nonane derivatives |
| 01/26/2000 | CN1242194A Calcium ion concentration liquid and process for producing same |
| 01/26/2000 | CN1048722C (S) (+)-2-ethoxy-4-[N-[1-(2-piperidino-phenyl)-3-methyl-1-butyl]-aminocarbonylmethyl]-benzoic acid pharmaceutical compositions contg. same, and process for prepn. |
| 01/25/2000 | US6017916 Nonpeptide endothelin antagonists I |
| 01/25/2000 | US6017915 Heterocyclic compounds |
| 01/25/2000 | US6017908 3-EPI vitamin D2 compounds and uses thereof |
| 01/25/2000 | US6017879 Template associated NPY Y2-receptor agonists |
| 01/25/2000 | US6017876 Monosuccinylated exclusively a n-terminus |
| 01/25/2000 | US6017545 Mixed micellar delivery system and method of preparation |
| 01/25/2000 | US6017530 Promoting the growth of a monogastric or polygastric animal and efficiecy of fat digestion |
| 01/25/2000 | CA2053231C Novel vitamin d analogues |
| 01/20/2000 | WO2000003015A2 Human transport protein homologs |
| 01/20/2000 | WO2000002911A2 INTERACTION OF HUMAN BETA AMYLOID PRECURSOR PROTEIN (β-APP) WITH HUMAN LON-PROTEASE LIKE PROTEIN (HSLON) |
| 01/20/2000 | WO2000002881A2 Use of cysteine derivatives for preparing a medicine for treating pathologies resulting from the formation of heterotrimeric g protein |
| 01/20/2000 | WO2000002851A1 Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 01/20/2000 | WO2000002850A2 Sulfonylamino carboxylic acid n-arylamides as guanylate cyclase activators |
| 01/20/2000 | WO2000002841A1 Water-soluble zinc pyruvates or their hydrates, method for the production thereof and their use |
| 01/20/2000 | WO2000002839A1 Cytokine production and tyrosine kinase inhibitors |
| 01/20/2000 | WO2000002558A1 Use of prenyltransferase inhibitors for preparing a medicine for treating pathologies resulting from heterotrimeric g protein membrane fixation |
| 01/20/2000 | WO2000002543A2 Antihypersensitive combination of valsartan and calcium channel blocker |
| 01/20/2000 | WO2000002541A1 Transdermal plaster containing at least one active ingredient which influences blood serum lipid levels |
| 01/20/2000 | WO2000002455A1 Hypericin and hypericum extract: specific t-type calcium channel blocker, and their use as t-type calcium channel targeted therapeutics |
| 01/20/2000 | WO1999059526A3 Protease inhibitors |
| 01/20/2000 | WO1999058518A3 Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia |
| 01/20/2000 | WO1999053052A3 Srebp-2-deficient cell lines |
| 01/20/2000 | WO1999051742A3 Dadd, death activator death domain protein |
| 01/20/2000 | WO1999034787A3 Fat-binding polymers |
| 01/20/2000 | CA2337261A1 Use of prenyltransferase inhibitors for preparing a medicine for treating pathologies resulting from heterotrimeric g protein membrane fixation |
| 01/20/2000 | CA2332625A1 Interaction of human beta amyloid precursor protein (.beta.-app) with human lon-protease like protein (hslon) |
| 01/20/2000 | CA2332307A1 Human transport protein homologs |
| 01/19/2000 | EP0972837A2 Ubiquitin specific protease like protein |
| 01/19/2000 | EP0972769A1 Novel amide derivatives and medicinal compositions thereof |
| 01/19/2000 | EP0972768A1 Process for producing optically active imidazole compounds, intermediates for synthesizing the same, and process for producing the same |
| 01/19/2000 | EP0972053A1 Novel human serine carboxypeptidase |
| 01/19/2000 | EP0972020A1 Insulin-like growth factor agonist peptides |
| 01/19/2000 | EP0971957A1 Polypeptide with appetite regulating activity |
| 01/19/2000 | EP0971952A2 Diagnosis method and reagents |
| 01/19/2000 | EP0971950A2 Secreted proteins and polynucleotides encoding them |
| 01/19/2000 | EP0971917A1 Thiazolidinedione and oxazolidinedione derivatives having antidiabetic, hypolipidaemic and antihypertensive properties |